Photo by cdc from unsplash
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to become the fifth endemic human coronavirus (eHCoV), which would lead to severe SARS-CoV-2–associated pneumonia occurring seasonally (1). A better… Click to show full abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to become the fifth endemic human coronavirus (eHCoV), which would lead to severe SARS-CoV-2–associated pneumonia occurring seasonally (1). A better understanding of eHCoV-associated pneumonia would help prepare for the postpandemic era. Using 10-year prospective cohort data, we evaluated the clinical characteristics and outcomes of severe eHCoV-associated pneumonia compared with those of severe influenza virus (IFV)–associated pneumonia.
Journal Title: American Journal of Respiratory and Critical Care Medicine
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!